Luke Pase and Prof. Fujiwara discuss how new targeting strategies and scalable manufacturing approaches are advancing ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

The latest update to the ESM protein language model series supports binder design and protein function mapping for therapeutic discovery.

David Chang, M.D., Ph.D., to Transition from President and Chief Executive Officer Following Eight Years of Outstanding Leadership and Continue to Serve on the Board of Directors Zachary Roberts, M.D.

A recent review from Japan has outlined how regulatory T cell therapies, including chimeric antigen receptor-engineered and gene-edited universal cell products, could help to induce donor-specific ...

Baron Opportunity Fund declined in the first quarter but outperformed its benchmark, the Russell 3000 Growth Index.

Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 1:30 PM EDTCompany ParticipantsDaniel Skovronsky - ...

A multicentre clinical trial led by Washington University School of Medicine in St Louis has shown that donor stem cells ...

The cost of CAR T-cell therapy means that the highly effective cancer treatment is unavailable in many parts of the world.